Drug therapy to aid in smoking cessation: Tips on maximizing patients' chances for success

Lowell C. Dale, Richard D. Hurt, James Taylor Hays

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

The arsenal of pharmacologic agents available for smoking cessation has expanded in the last few years, and it is likely to continue to do so. It is important that practicing physicians keep abreast of new methods as they become available and encourage patients who smoke to undertake cessation measures. Nicotine-replacement therapy is available in gum, patch, nasal spray, or inhaler form, and bupropion therapy aids in smoking cessation through dopaminergic activity. The foundation of effective intervention is likely to remain unchanged: an individualized plan addressing behavioral, addictive, pharmacologic, and relapse-prevention components. In addition to the necessary information about treatment choices, physicians should offer motivation, support, and follow-up to their patients who wish to quit smoking.

Original languageEnglish (US)
Pages (from-to)75-89
Number of pages15
JournalPostgraduate Medicine
Volume104
Issue number6
StatePublished - 1998

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this